A validated clinical decision tool for patients presenting to the emergency department with chest pain, created by Wake Forest University School of Medicine physicians. For patients presenting with chest pain, the HEART Pathway algorithm has been shown to reduce patient length of stay by 12 hours, reduce cost by 14 percent per patient, and results in a MACE rate of < 1%.
If interested in licensing the HEART Pathway for use at your institution please contact us via our website.
HEART Pathway randomized controlled trial: http://www.ncbi.nlm.nih.gov/pubmed/25737484
Chest pain is a top cause of US ED visits. Eight to ten million patients with chest pain present to an ED annually in the United States. More than half of Emergency Department patients with chest pain receive lengthy cardiac evaluations in an chest pain unit or inpatient ward, with an annual cost $10-13 billion. Less than ten percent of patients have an acute coronary syndrome (ACS). Two to five percent of patients with myocardial infarctions are inappropriately discharged from the ED every year. Missed ACS is a top cause of malpractice claims.
What is the HEART Pathway?
The HEART Pathway is designed for more accurate cardiac risk stratification for patients presenting to the ER with Chest Pain. The HEART Pathway is similar to the HEART Score but has been modified by researchers at Wake Forest University School of Medicine.
The HEART Pathway has been validated by researchers at Wake Forest University School of Medicine and is used on a daily basis at Wake Forest and our affiliate emergency departments.
The HEART Pathway randomized controlled trial (Mahler et al, Circ CVQO J, 2015.) has demonstrated the benefits of the HEART Pathway compared with usual care. When HEART Pathway was applied to chest pain patients researchers found an increase in early discharge rate from 18% to 39% with a cost savings of over $200 per patient.
The HEART Pathway assists providers with answering the following questions:
Should I admit my patient for stress testing or can I discharge my patient from the Emergency Room?
What is the likelihood that my patient’s presenting symptoms represent ACS?
What is the likelihood that my patient will have an ACS event in the near future (within 30 days)?
- Fixed bug affecting some users that caused a crash before results could be viewed.
Ratings and Reviews
Bug fixed, great app
I am an EM resident at a major academic facility in the US. This is a useful app I apply daily in the ED for my chest pain, ACS-rule out patients. The recent patch fixed a bug that apparently was causing occasional app crashes before results could be viewed, however I’ve personally never had that issue. Awesome work with this.
Update fixes crash issue
The update fixes the crash issue
Better than heart score
This is the actual algorithm from the circulation study, not the heart score / heart pathway that is incorrectly labeled on Mdcalc.
- Impathiq Inc.
- 16.4 MB
Requires iOS 8.2 or later. Compatible with iPhone, iPad, and iPod touch.
- Age Rating
- Rated 12+ for the following:
- Infrequent/Mild Medical/Treatment Information
- © 2018, Impathiq, Inc. All rights reserved.
With Family Sharing set up, up to six family members can use this app.